Your people are already using AI. They’re writing code with it, analyzing data with it, drafting regulatory documents with it – with or without your governance frameworks, your ontology standards, or your validation processes. The question isn’t whether to enable this; it’s whether you’re going to lead it or clean up after it. The […]
This end-of-summer seminar takes a longitudinal view of AI across the full drug development pipeline — from the earliest stages of target identification and validation through to clinical trial design and execution. Through in-depth case studies and expert presentations, participants will examine where AI is delivering genuine, measurable value and where significant challenges remain. […]
